DAX rises as bond pressure eases and tech leads

Bond markets were the key swing factor for investors. French yields had surged in recent weeks on fiscal and political concerns, but the mood improved after Marine Le Pen proposed a budget plan aimed at cutting France’s deficit below 3% of GDP by 2032, easing some of the stress that had been weighing on European equities.

The Dax also benefited from the view that its technical picture remains constructive. Traders noted the index continued to hold above its 200-day moving average, even after a pullback from the 25,500 area, which helped limit selling pressure and encouraged dip buying.

Still, the rally looked selective rather than broad-based. Pharma names such as Merck KGaA, Qiagen, Sartorius and Evotec gained between roughly 3% and 5%, while Fraport slipped more than 2% after Barclays turned more cautious on the stock.

For investors, the message is that Frankfurt shares remain hostage to the same two forces that have driven recent trading: the resilience of mega-cap tech and the direction of bond yields. A steadier rate backdrop could keep the Dax supported, but renewed pressure on French or US sovereign debt, or a reversal in tech momentum, would quickly test that optimism.